Portal Hypertension Terminated Phase 2 Trials for Cobiprostone (DB05514)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00737594Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionTreatment